5633.5000 31.50 (0.56%)
NSE Jul 24, 2026 15:31 PM
Volume: 55,151
 

5633.50
0.56%
ICICI Securities Limited
Alkem Laboratories’ CEO, Dr. Vikas Gupta, is targeting double-digit revenue growth in the medium term, driven by strong hold in India (68% of sales), other international markets and new ventures.
Alkem Laboratories Ltd. is trading above all available SMAs
More from Alkem Laboratories Ltd.
Recommended